Viemed Healthcare (NASDAQ:VMD) Azioni

Viemed Healthcare

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

Viemed Healthcare Inc

KLEA HLDG by KLEA HLDG.

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 0.2% on Wednesday.
The Dow traded up 0.64% to 41,090.68 while the NASDAQ fell 0.20% to 17,655.00. The S&amp;P 500 also rose, gaining, 0.20% to 5,618.00.
Check This Out: <a href="https://www.benzinga.com/25/05/45251087/robinhood-zscaler-palo-alto-and-a-real-estate-stock-on-cnbcs-final-trades">Robinhood, Zscaler, Palo Alto And A Real Estate Stock On CNBC&#8217;s &#8216;Final Trades&#8217;</a>
Leading and Lagging Sectors Consumer discretionary shares rose by 1.2% on Wednesday.
In trading on Wednesday, materials stocks fell by 0.6%.
Top Headline
Uber Technologies, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) reported weaker-than-expected revenue for the first quarter on Wednesday.
The company reported a quarterly revenue growth of 14% year-on-year to $11.53 billion, missing the analyst consensus estimate of $11.62 billion. Uber reported adjusted EPS of 83 cents, which beat the analyst consensus estimate of 50 cents.
Gross Bookings grew 14% Y/Y to $42.82 billion. Uber expects fiscal second-quarter 2025 gross bookings of $45.75 billion-$47.25 billion and adjusted EBITDA of $2.02 billion-$2.12 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Asset Entities Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) shares shot up 265% to $2.25 after the company announced it entered into a merger agreement with Strive Asset Management to be the first publicly traded asset management bitcoin treasury company.</li>
<li>Shares of Porch Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) got a boost, surging 51% to $9.56 following a first-quarter revenue and EPS beat. Additionally, the company raised its FY25 sales guidance above estimates.</li>
<li>CuriosityStream Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) shares were also up, gaining 52% to $5.02 after the company reported better-than-expected first-quarter financial results and issued second-quarter sales guidance above estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Myriad Genetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) shares dropped 35% to $4.70 after the company reported a first-quarter sales miss and cut its FY25 guidance below estimates.</li>
<li>Shares of Vast Renewables Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) were down 62% to $0.1427 after the company announced it voluntarily delisted from the Nasdaq.</li>
<li>The Hain Celestial Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) was down, falling 49% to $1.40 after the company reported worse-than-expected third-quarter results, guided for a 5%-6% YoY decline in FY25 organic net sales, announced the departure of its CEO and said its board hired Goldman Sachs for a portfolio review.</li>
</ul>
Commodities In commodity news, oil traded down 1% to $58.50 while gold traded down 0.7% at $3,399.30.
Silver traded down 1.1% to $33.030 on Wednesday, while copper fell 2.6% to $4.6560.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.48%, while Spain's IBEX 35 Index fell 0.43%. Germany's DAX 40 fell 0.36% and France's CAC 40 fell 0.88% during the session.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.14%, Hong Kong's Hang Seng Index gaining 0.13%, China's Shanghai Composite Index rising 0.80% and India's BSE Sensex gaining 0.13%.
Economics
U.S. mortgage application volumes climbed by 11% from the previous week during the week ending May 2.
The EIA reported that crude oil inventories in the U.S. declined by 2.032 million barrels in the week ended May 2, compared to market estimates of a 1.7 million barrel fall.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45251088/top-3-financial-stocks-that-may-plunge-in-may">Top 3 Financial Stocks That May Plunge In May</a> </li>
</ul>
Photo via Shutterstock

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ASST

CURI

HAIN

MYGN

PRCH

UBER

VSTE

Crude Oil Falls 1%; Uber Sales Miss Estimates

Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) activated its long-anticipated Pectra upgrade on May 7, marking a pivotal step in the network&#8217;s evolution since the <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37667987/ethereum-dencun-upgrade-drops-layer-2-fees-by-99">Dencun fork last year.</a>
The upgrade went live at 6:05 a.m. ET, with finality confirmed just over ten minutes later.
Pectra introduces sweeping changes across the Ethereum protocol, most notably EIP-7702, a feature that redefines how externally owned accounts (EOAs) interact with smart contracts. 
For the first time, regular user wallets can execute contract logic while maintaining the same address, paving the way for smarter, more flexible user accounts.
EIP-7702 is seen as foundational for full account abstraction, where users can batch transactions, skip manual token approvals and interact seamlessly across apps.
The upgrade also brings changes to Ethereum's validator model with EIP-7251, lifting the staking cap from 32 to 2,048 ETH per validator. 
This allows larger stakers to consolidate capital more efficiently, improving protocol operations and reward distribution. 
Additionally, EIP-7691 doubles the number of blobs per block from three to six, improving Layer-2 throughput and lowering rollup transaction costs.
Still, the upgrade isn't without its tradeoffs.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45253032/anthony-scaramucci-gives-donald-trump-b-or-a-on-crypto-but-warns-presidential-meme-coin-defi-project-risk-derailing-policy-progress">Anthony Scaramucci Gives Donald Trump &#8216;B+ Or A-&#8216; On Crypto But Warns Presidential Meme Coin, DeFi Project Risk Derailing Policy Progress</a>
In a note sent to Benzinga, Muriel Médard, MIT professor and co-founder of Optimum, pointed out a rising bottleneck: network bandwidth. 
"With Pectra live, bandwidth has become the binding constraint, especially as blobs must be gossiped across the peer-to-peer layer," she said. "Ethereum's ability to propagate data efficiently and predictably will define how far it can scale."
She added that as blob sizes grow, reducing variability, not just increasing average bandwidth, is essential. 
"Unpredictability undermines reliability across rollups and apps. This is now core infrastructure," Médard stressed.
Security experts have also raised concerns about EIP-7702's deeper implications. 
In a blog <a href="https://www.certik.com/resources/blog/pectras-eip-7702-redefining-trust-assumptions-of-externally-owned-accounts">post</a>, CertiK, a blockchain security firm, warned that the upgrade breaks a longstanding assumption that EOAs cannot run contract code. 
As a result, contracts that rely on outdated patterns like <code>tx.origin == msg.sender</code> for reentrancy or flash loan protection may be vulnerable.
"The trust model has changed," CertiK said in a report. "EOAs can now execute logic, creating new risk vectors in contracts that didn't anticipate this behavior."
The firm cited recent activity on Binance Smart Chain, which adopted a similar upgrade called Pascal in March, where it observed suspicious transactions exploiting these assumptions.
Developers are being urged to update their codebases and abandon any logic that treats EOAs as inherently passive. 
Instead, industry-standard protections like reentrancy guards and proper logical constraints should replace fragile assumptions.
Despite these growing pains, the Pectra upgrade is widely seen as a necessary milestone. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45248407/rabbitx-founder-eyes-real-world-assets-and-liquidity-tokenization-as-the-future-of-perpetual-trading">RabbitX Founder Eyes Real-World Assets And Liquidity Tokenization As The Future Of Perpetual Trading</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

Ethereum's Pectra Upgrade Goes Live: Here's What You Need To Know

WIIM

PKOH

Park-Ohio Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results and cut its FY25 sales guidance with its midpoint below estimates.

Seagate Technology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>)&nbsp;is amid efforts to develop a <a target="_blank" href="https://www.benzinga.com/topic/seagate-technology" rel="noreferrer noopener">100-terabyte hard drive</a> by 2030.
Seagate&#8217;s chief commercial officer, BS Teh, <a target="_blank" href="https://www.cnbc.com/2025/05/07/seagate-to-triple-hard-drive-capacity-by-2030-to-meet-ai-demand.html" rel="noreferrer noopener">told</a> CNBC on Wednesday that the data storage firm aims to launch a drive with about three times the capacity of its top-notch hard drives by 2030.
The largest hard disk drive Seagate currently produces is the 36-terabyte Exos M model.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/04/45080030/western-digital-refocuses-after-post-sandisk-spin-off-as-analyst-highlights-ai-led-hdd-growth" rel="noreferrer noopener">Western Digital Refocuses Post-SanDisk Spin-Off As Analyst Highlights AI-Led HDD Growth</a>
Teh expressed conviction in strong demand, underlining the need for the 100-terabyte hard drive. Teh also said Seagate is amid efforts to counter climate concerns surrounding AI&#8217;s energy demands.
Teh expressed conviction in hard disk drive prospects, citing it as a much more sustainable device technology.
Big Tech&#8217;s 2025 <a target="_blank" href="https://www.benzinga.com/markets/25/02/43962882/meta-gears-up-for-ai-dominance-with-200-billion-data-center-project-report" rel="noreferrer noopener">AI infrastructure investments</a> included Amazon.com Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) $100 billion, followed by Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) at $80 billion each, and Meta committing over $60 billion.
Microsoft expects to spend $80 billion on data centers&nbsp;in fiscal 2025.
February reports indicated Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is in talks to build an AI data center campus that could exceed $200 billion in costs.
Seagate Technology Holdings stock gained close to 9% year-to-date. It reported <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/04/45116667/whats-going-on-with-seagate-technology-stock-wednesday" rel="noreferrer noopener">third-quarter sales</a> of $2.16 billion (versus $1.66 billion Y/Y), missing the analyst estimate of $2.31 billion. It reported adjusted earnings per share of $1.90, missing the analyst estimate of $2.09.
Seagate expects fourth-quarter revenue of&nbsp;$2.25 billion-$2.55 billion, versus the&nbsp;$2.43 billion estimate, and adjusted earnings of $2.20-$2.60&nbsp;per share, versus the&nbsp;$2.20&nbsp;analyst estimate.
Price Action: STX stock is up 1.16% at $94.99 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45237744/on-semiconductor-sees-green-shoots-in-industrial-auto-shift-as-analysts-stay-cautious" target="_blank" rel="noreferrer noopener">ON Semiconductor Powers Through Expectations, But Analysts Dial Down Targets On Margin Squeeze</a></li>
</ul>
Photo via Shutterstock

Tech

Media

AMZN

GOOG

GOOGL

MSFT

Seagate Bets On Mega-Sized, Sustainable Drives As AI Sparks Record Data Demand

Energizer Holdings shares are trading lower after Canaccord Genuity maintained a Hold rating on the stock and lowered its price target from $31 to $27. Also, UBS maintained a Neutral rating on the stock and lowered its price target from $28 to $26.

<a href="https://www.gov.uk/government/news/mhra-approves-teprotumumab-as-the-first-uk-treatment-for-adults-with-moderate-to-severe-thyroid-eye-disease-ted#:~:text=As%20with%20all%20products%2C%20the%20MHRA">https://www.gov.uk/government/news/mhra-approves-teprotumumab-as-the-first-uk-treatment-for-adults-with-moderate-to-severe-thyroid-eye-disease-ted#:~:text=As%20with%20all%20products%2C%20the%20MHRA</a>
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 7 May 2025, approved teprotumumab (Tepezza). This is the first medicine to be licensed in the UK for adult patients with moderate to severe Thyroid Eye Disease (TED).&nbsp;
TED is an autoimmune condition where the immune system attacks the muscles and fat around the eyes.&nbsp; In TED, the immune system activates a protein called IGF-1R, causing inflammation and swelling in these tissues. Tepezza is designed to bind to IGF-1R to block its activation and signalling.&nbsp;
This medicine is administered via an intravenous drip directly into a vein by a healthcare professional.

Biotech

General

AMGN

MHRA Approves Teprotumumab As The First UK Treatment For Adults With Moderate To Severe Thyroid Eye Disease

Steven Madden Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOO#NASDAQ">SHOO</a>) shares are <a href="https://www.benzinga.com/movers">trading higher on Wednesday</a> after the first-quarter FY25 earnings.
The company reported <a href="https://www.benzinga.com/pressreleases/25/05/g45248046/steve-madden-announces-first-quarter-2025-results">first-quarter revenue growth</a> of 0.2% year-on-year to $551.38 million, missing the analyst consensus estimate of $557.34 million.
Revenue for the wholesale business increased 0.2% to $439.3 million, and Direct-to-Consumer revenue fell 0.2% to $112.1 million.
Gross profit margin expanded 20 basis points Y/Y to 40.9%.
Also Read: <a href="https://www.benzinga.com/25/05/45237060/despite-nikes-executive-overhaul-ongoing-challenges-persist-says-analyst">Nike Revamps C-Suite, &#8216;Win Now&#8217; Strategy Faces Profit Pressure: Analyst</a>
The operating margin was 9.7%, and operating income for the quarter was $53.5 million. Adjusted EPS of 60 cents<a href="https://www.benzinga.com/earnings"> beat the consensus </a>estimate of 45 cents.
Steven Madden held $114.7 million in cash and equivalents as of March 31, 2025. Cash used in operating activities for the quarter totaled $(18.8) million.
The company&#8217;s board of directors approved a quarterly cash dividend of 21 cents per share. The dividend is payable on June 20, 2025, to stockholders of record as of the close of business on June 9, 2025.
The company ended the quarter with 314 brick-and-mortar retail stores and five e-commerce websites.
Edward Rosenfeld, chairman and CEO, commented, &#8220;Looking ahead, we face meaningful near-term headwinds and heightened uncertainty due to the impact of new tariffs on goods imported into the U.S.&#8221;
Outlook: The company is withdrawing the 2025 financial guidance provided in its earnings release on Feb. 26, 2025, due to macroeconomic uncertainty related to the impact of new tariffs on goods imported into the U.S.
SHOO Price Action:&nbsp;SHOO shares traded higher by 13.74% at $22.90 at publication on Wednesday.
Read Next: • <a href="https://www.benzinga.com/25/05/45236630/ford-outperforms-in-q1-faces-tariff-challenges-ahead-say-analysts">Ford Outperforms In Q1, Faces Tariff Challenges Ahead, Say Analysts</a>
Photo: Shutterstock

Earnings

Earnings Beats

Movers

SHOO

Why Is Steve Madden's Stock Surging Today?

DNOW

DNOW hares are trading lower. The company reported Q1 financial results.

Mattel Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) shares have surged 9% to $17.16 since Tuesday's open, as investors respond to the company's better-than-expected first-quarter earnings.
What To Know: The toymaker posted <a href="https://www.benzinga.com/news/earnings/25/05/45209947/mattel-beats-q1-estimates-pauses-guidance-due-to-tariffs-plans-actions-to-mitigate-cost-impacts">revenue of $827 million</a>, surpassing analyst estimates of $786 million, and reported an adjusted loss of three cents per share—beating the expected 10-cent loss. 
Revenue grew 2% year-over-year, with North America up 3% and international markets up 1%. Gross margin improved to 49.4%, up from 48% a year ago.
CEO Ynon Kreiz described the quarter as strong, citing brand strength and operational resilience. Mattel repurchased $160 million in stock during the quarter and reaffirmed its $600 million buyback target for 2025. 
However, due to macroeconomic volatility and <a href="https://www.benzinga.com/trading-ideas/25/05/45227056/trumps-tariffs-hit-mattels-barbies-will-americans-pay-a-couple-of-bucks-more-as-president-predicts">uncertainty around U.S. tariffs</a>, the company paused its full-year 2025 guidance, noting it will resume once visibility improves.
To counter rising costs, Mattel plans to accelerate supply chain diversification, optimize product sourcing, and raise prices. The company also increased its 2025 cost-saving goal from $60 million to $80 million, reinforcing its focus on efficiency as it navigates a turbulent economic environment.
Read Also: <a href="https://www.benzinga.com/25/05/45256871/energizer-holdings-analysts-cut-their-forecasts-after-q2-results">Energizer Holdings Analysts Cut Their Forecasts After Q2 Results</a>
<h2 class="wp-block-heading">How To Buy MAT Stock</h2>
By now you're likely curious about how to participate in the market for Mattel &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Mattel, which is trading at $17.16 as of publishing time, $100 would buy you 5.83 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MAT has a 52-week high of $22.06 and a 52-week low of $13.94.

Mattel Stock Jumps Following Q1 Results Despite Paused Guidance: What's Going On?

IMCR

Immunocore Holdings shares are trading higher after the company reported better-than-expected Q1 financial results.

CRSR

Corsair Gaming shares are trading lower after the company reported mixed Q1 financial results.

In a world increasingly defined by digital assets, borderless banking, and decentralized infrastructure, there is one foundational piece still lagging behind: identity. Who you are, how you prove it, and who controls that information are questions that financial institutions, regulators, and individuals are all racing to answer.
By 2030, the solution may come from an emerging concept already gaining traction in tech circles: self-sovereign identity (SSI). And if you&#8217;re paying attention to the future of finance, it&#8217;s time to understand why this quiet revolution in identity could reshape everything from KYC to asset access.
<h3 class="wp-block-heading">What Is Self-Sovereign Identity (SSI)?</h3>
Self-sovereign identity is a decentralized model that allows individuals to own, manage, and share their digital credentials without relying on a central authority. Instead of logging into banks, brokerages, or apps using credentials stored by third parties, users carry verifiable credentials in a digital wallet they control.
Think of it as a blockchain-secured passport that works across platforms—except you decide who sees what, and when.
SSI enables:
<ul>
<li>Reusable, verified digital credentials (e.g., age, citizenship, income proof)</li>
<li>Privacy-preserving access to services (only the data required is shared)</li>
<li>Elimination of centralized databases vulnerable to hacks</li>
</ul>
<h3 class="wp-block-heading">Why Finance Needs SSI</h3>
Today, financial access is built on a patchwork of identity checks: KYC, AML, credit scoring, and jurisdictional gatekeeping. These systems are:
<ul>
<li>Costly to maintain</li>
<li>Friction-heavy for users</li>
<li>Prone to data breaches</li>
<li>Incompatible across borders</li>
</ul>
SSI fixes these problems by creating a portable, tamper-proof identity layer that can follow the user from country to country, platform to platform.
<h3 class="wp-block-heading">Real-World Applications Already Emerging</h3>
<ul>
<li>KYC Simplification: Instead of uploading documents to every exchange, wallet, or bank, users could submit a single verified credential.</li>
<li>Borderless Finance: SSI enables seamless onboarding for global DeFi platforms without sacrificing compliance.</li>
<li>Reputation Systems: Investors and lenders can assess trustworthiness through on-chain activity, verifiable income, or education records.</li>
<li>Embedded Compliance: Regulators could approve identity schemas without needing constant data collection.</li>
</ul>
<h3 class="wp-block-heading">Who&#8217;s Building It?</h3>
Several players are leading the charge:
<ul>
<li>Microsoft and ConsenSys with their ION project</li>
<li>Sovrin Foundation, focused on decentralized identity networks</li>
<li>World Economic Forum, actively shaping digital ID policy frameworks</li>
<li>European Union, integrating SSI concepts into its eIDAS 2.0 regulation</li>
</ul>
Even the private sector is catching on, with startups integrating digital ID into financial onboarding and tokenized asset platforms.
<h3 class="wp-block-heading">What Investors Should Be Watching</h3>
SSI isn&#8217;t just a technical upgrade. It&#8217;s an investment theme with implications across fintech, cybersecurity, DeFi, and Web3. Key areas to monitor:
<ul>
<li>Wallets and platforms that support verified credentials</li>
<li>SSI integration into tokenized investment platforms</li>
<li>Regulatory clarity on digital ID standards</li>
<li>Companies building identity infrastructure (e.g., verifiers, issuers, networks)</li>
</ul>
<h3 class="wp-block-heading">Final Thought: Identity Is the Next Frontier in Finance</h3>
In the age of tokenized assets, decentralized finance, and programmable money, identity is the glue that holds everything together. Without a trusted, flexible, and user-controlled way to prove who we are, the future of finance remains incomplete.
Self-sovereign identity promises a future where access to capital, credit, and opportunity isn't just efficient. It's fair, secure, and truly global.
By 2030, the winners in finance won&#8217;t just be those who built the best portfolios. They'll be the ones who built trust without borders.

Fintech news covering the emerging Financial Technology services sector

Fintech

Opinion

Why Self-Sovereign ID Will Reshape Finance By 2030

Wedbush analyst Daniel Ives maintains Qualys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) with a Outperform and lowers the price target from $160 to $145.

Price Target

Analyst Ratings

QLYS

Wedbush Maintains Outperform on Qualys, Lowers Price Target to $145

CrowdStrike Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) shares are trading lower Wednesday after the cybersecurity company announced a new strategic initiatives, including <a href="https://www.benzinga.com/quote/CRWD/earnings">a workforce reduction</a>.
What Happened: CrowdStrike said in a filing Wednesday morning that it adopted a strategic plan to make operations more efficient. The plan includes cutting approximately 500 roles, or 5% of the company&#8217;s global workforce in an effort to operate with discipline as it continues to target scaling up to $10 billion in annual recurring revenue. 
CrowdStrike expects to incur approximately $36 million to $53 million in charges related to the plan. $7 million of those charges are expected to be recognized in the first quarter. The actions are expected to be substantially complete by the end of the second quarter.
CrowdStrike said it expects first-quarter financial results to be in line with or above guidance provided in its <a href="https://www.benzinga.com/news/earnings/25/03/44127302/crowdstrike-q4-earnings-revenue-beat-eps-beat-strong-momentum-shares-slide-on-soft-guidance">fourth-quarter earnings release</a>. CrowdStrike previously guided for first-quarter revenue of $1.1 billion to $1.106 billion, and first-quarter adjusted earnings of 64 cents to 66 cents per share. 
CrowdStrike also reaffirmed its full-year guidance of $4.74 billion to $4.81 billion in revenue and adjusted earnings of $3.33 to $3.45 per share.
CrowdStrike is due to report first-quarter financial results after the market close on June 3. 
CRWD Price Action: <a href="http://benzinga.com/quote/crwd">CrowdStrike shares</a> were down 3.81% at $426.31 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/05/45229107/paul-tudor-jones-warns-ai-could-kill-50-of-humanity-without-proper-oversight-were-creating-something-thats-really-dangerous">Paul Tudor Jones Warns AI Could &#8216;Kill 50% Of Humanity&#8217; Without Proper Oversight: &#8216;We&#8217;re Creating Something That&#8217;s Really Dangerous&#8217;</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Peter+Vandenbelt">VDB Photos</a>/Shutterstock.

Guidance

CRWD

CrowdStrike Stock Is Sliding Wednesday: What's Going On?

Wedbush analyst Daniel Ives reiterates IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) with a Outperform and maintains $300 price target.

Reiteration

Wedbush Reiterates Outperform on IBM, Maintains $300 Price Target

L3Harris Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) has outperformed the market over the past 20 years by 2.41% on an annualized basis producing an average annual return of 10.57%. Currently, L3Harris Technologies has a market capitalization of $40.79 billion. 
Buying $1000 In LHX: If an investor had bought $1000 of LHX stock 20 years ago, it would be worth $7,462.04 today based on a price of $218.19 for LHX at the time of writing.
<h3>L3Harris Technologies's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746634536_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In L3Harris Technologies 20 Years Ago Would Be Worth Today

MBIA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MBI#NYSE">MBI</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-08. Here's what investors need to know before the announcement.
Analysts estimate that MBIA will report an earnings per share (EPS) of $-0.07. 
Investors in MBIA are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.37, which was followed by a 13.53% drop in the share price the next day.
Here's a look at MBIA's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.11</td>
<td>-0.33</td>
<td>-0.3</td>
<td>-0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.48</td>
<td>0</td>
<td>-2.9</td>
<td>-0.52</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-14.000000000000002%</td>
<td>7.000000000000001%</td>
<td>-8.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746634477_0.png" alt="eps graph" />
<h3>Tracking MBIA's Stock Performance</h3>
Shares of MBIA were trading at $4.64 as of May 06. Over the last 52-week period, shares are down 30.21%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/MBI/earnings">To track all earnings releases for MBIA visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of MBIA's Earnings

In today&#8217;s digital-first economy, the financial sector is undergoing a seismic shift. From personal banking apps to complex trading platforms, financial services are increasingly powered by technology. At the heart of this transformation lies custom fintech software—tailor-made digital solutions designed to meet the specific needs of businesses operating in finance. As a business leader, understanding how and when to invest in such technology is crucial not just for staying competitive, but for ensuring long-term growth and innovation.
This strategic guide aims to demystify the process of investing in custom fintech software. It explores why businesses are moving away from off-the-shelf solutions, the key benefits and risks, how to select the right development partner, and what returns to expect.
<h3 class="wp-block-heading">The Case for Custom Fintech Software</h3>
While generic fintech tools can offer fast implementation and lower upfront costs, they often come with limitations: restricted functionality, poor integration capabilities, and limited scalability. Custom software, on the other hand, is designed around your business model, user requirements, and long-term objectives. It gives you full control over features, design, compliance, and data security.
In sectors like banking, insurance, and asset management—where security, precision, and regulation are critical—custom solutions provide the agility and specificity that standard tools can&#8217;t match.
<h3 class="wp-block-heading">Key Benefits of Custom Solutions</h3>
<h4 class="wp-block-heading">1. Competitive Differentiation</h4>
Custom fintech software allows businesses to introduce unique features, user experiences, and workflows that are hard for competitors to replicate. Whether it&#8217;s a personalized client portal or a proprietary risk assessment tool, the ability to innovate sets you apart in a crowded marketplace.
<h4 class="wp-block-heading">2. Enhanced Data Security &amp; Compliance</h4>
The financial industry operates under intense regulatory scrutiny. Custom solutions can be built to meet specific regulatory requirements (like GDPR, PCI-DSS, or SOX) right from the design phase. You also gain greater control over your data infrastructure, reducing third-party vulnerabilities.
<h4 class="wp-block-heading">3. Seamless Integration</h4>
Most financial businesses rely on a range of systems—from CRMs and ERPs to trading engines and payment gateways. Custom software ensures smooth interoperability with existing infrastructure, eliminating inefficiencies and data silos.
<h4 class="wp-block-heading">4. Scalability and Flexibility</h4>
Off-the-shelf software can be a bottleneck as your business grows. Custom applications, in contrast, are designed with your growth trajectory in mind. You can scale features, expand to new markets, or integrate emerging technologies like blockchain or AI without major overhauls.
<h3 class="wp-block-heading">Key Considerations Before Investing</h3>
<h4 class="wp-block-heading">1. Defining Clear Business Objectives</h4>
Before committing to custom development, it's vital to articulate the problem you&#8217;re solving. Are you improving internal operations? Creating a better customer experience? Meeting a new regulatory mandate? Clear goals will guide the development roadmap and ROI measurement.
<h4 class="wp-block-heading">2. Budgeting Beyond Development</h4>
Many business leaders focus on the initial development cost, overlooking post-launch needs like maintenance, updates, cybersecurity, and user training. A complete financial plan should cover the total cost of ownership over time.
<h4 class="wp-block-heading">3. Choosing the Right Tech Stack</h4>
Your choice of programming languages, frameworks, and databases will influence the software&#8217;s performance, scalability, and maintainability. Consult with experienced architects and make decisions that align with your long-term business and technology strategy.
<h4 class="wp-block-heading">4. Selecting a Development Partner</h4>
Partnering with a trustworthy and skilled software development company is one of the most critical decisions in this journey. If your business operates across Europe, for instance, choosing a software development company in France could offer the dual advantage of EU regulatory familiarity and high engineering standards.
<h3 class="wp-block-heading">Evaluating ROI and Measuring Success</h3>
Custom fintech software is a significant investment, and business leaders must measure returns beyond just revenue. Here are key performance indicators (KPIs) to track:
<ul>
<li>Operational Efficiency: Are you saving time or resources compared to your previous tools?</li>
<li>Customer Satisfaction: Is your client experience more seamless or personalized?</li>
<li>Compliance and Risk Management: Have regulatory issues decreased or become easier to manage?</li>
<li>Market Expansion: Has the software enabled entry into new markets or services?</li>
</ul>
Success also depends on user adoption, system performance, and ongoing innovation. Make sure to gather feedback and iterate quickly.
<h3 class="wp-block-heading">Risks and How to Mitigate Them</h3>
<h4 class="wp-block-heading">1. Scope Creep</h4>
Without a clear scope, development projects can spiral in time and cost. Establish a minimum viable product (MVP) with essential features and follow agile practices to add features iteratively.
<h4 class="wp-block-heading">2. Vendor Dependence</h4>
Custom solutions often tie you to a particular development team. Ensure proper documentation, code ownership rights, and consider source code escrow agreements to protect your business.
<h4 class="wp-block-heading">3. Compliance Gaps</h4>
Working with teams unfamiliar with financial regulations can lead to costly mistakes. Always vet your developers&#8217; experience with industry-specific compliance and certifications.
<h4 class="wp-block-heading">4. Cybersecurity Threats</h4>
Custom doesn't mean immune. Ensure security is built into the development lifecycle with threat modeling, penetration testing, and regular audits.
<h3 class="wp-block-heading">Real-World Use Cases</h3>
<ul>
<li>Wealth Management Firms: Built custom platforms for clients to view portfolios, receive financial advice, and execute trades.</li>
<li>Insurtech Startups: Developed underwriting engines that automate policy issuance based on real-time risk analysis.</li>
<li>Retail Banks: Created mobile apps with AI-powered customer service and personalized financial planning tools.</li>
<li>Crypto Exchanges: Built scalable trading engines with custom compliance modules for different jurisdictions.</li>
</ul>
<h3 class="wp-block-heading">Final Thoughts</h3>
Investing in custom fintech software is not merely a technical decision; it&#8217;s a strategic business move. It allows organizations to respond to market needs faster, offer differentiated value, and maintain compliance in an ever-evolving regulatory landscape.
However, success requires more than capital. It demands vision, planning, and the right partners. For business leaders willing to invest the time and resources, custom fintech solutions can offer an unmatched edge in today&#8217;s technology-driven financial ecosystem.
Whether you&#8217;re a startup entering the fintech space or an established institution looking to modernize, the opportunity to innovate through custom software has never been greater. The key is to approach it strategically—as an investment in your company's future agility, security, and growth.

Investing in Custom Fintech Software: A Strategic Guide for Business Leaders

Wedbush analyst Daniel Ives maintains Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) with a Outperform and lowers the price target from $155 to $140.

DDOG

Wedbush Maintains Outperform on Datadog, Lowers Price Target to $140

Teva Pharmaceutical Industries Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) stock is trading higher on Wednesday after the company&#8217;s first-quarter 2025 financial results. <a href="https://www.benzinga.com/pressreleases/25/05/g45248070/teva-reports-ninth-consecutive-quarter-of-growth-in-q1-2025-with-key-innovative-medicines-growing-" target="_blank" rel="noreferrer noopener">Here are the details</a>.
Teva reported revenue of $3.89 billion, up 5% year-over-year, missing analyst estimates of $4.00 billion, according to&nbsp;<a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
The increase was driven by higher revenues from Austedo in the U.S. segment. Austedo&#8217;s worldwide revenues were $411 million in Q1 2025, an increase of 39% in local currency terms compared to Q1 2024.
<ul>
<li>U.S. Austedo revenues increased by 40% to $396 million, mainly due to volume growth, including the approval of Austedo XR, a once-daily pill, in May 2024.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/05/45199025/why-is-israel-based-generic-drug-focused-teva-pharmaceutical-stock-trading-higher-on-monday" rel="noreferrer noopener">Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?</a>
Ajovy&#8217;s global revenues were $139 million in Q1 2025, an increase of 26% in local currency terms compared to Q1 2024.
<ul>
<li>US Ajovy&nbsp;revenues were $53 million, an increase of 18% compared to the first quarter of 2024, mainly due to volume growth.</li>
<li>Uzedy&#8217;s global revenues are $39 million in Q1 2025.</li>
<li>The generics business grew across all regions—it increased by 5% in the U.S., 1% in Europe, and 2% in International Markets, all in local currency terms, compared to Q1 2024.</li>
</ul>
The company reported first-quarter adjusted earnings of 52 cents per share, beating <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">estimates of 48 cents per share</a>.
Gross profit margin&nbsp;was 48.2% in the first quarter of 2025, compared to 46.4% a year ago, and adjusted gross profit margin&nbsp;was 52.8% compared to 51.4% in the first quarter of 2024.
<ul>
<li>The increase in both gross profit margin and non-GAAP gross profit margin was mainly due to a favorable mix of products, primarily driven by higher revenues from Austedo, partially offset by a negative impact from foreign exchange rate movements, including hedging effects.</li>
</ul>
Richard Francis, Teva&#8217;s president and CEO, said, &#8220;Now entering the Acceleration Phase of our Pivot to Growth Strategy, we have a clear roadmap to continue Teva&#8217;s transformation into a leading biopharmaceutical company with an expected 30% operating margin, and today have announced ~$700 million net savings by 2027. We&#8217;re accelerating innovative growth and strengthening our generics business, while streamlining our operations, sharpening our business, and optimizing processes. With these results, we are revising our 2025 outlook and reaffirming our 2027 targets.&#8221;
Guidance: Teva Pharmaceutical raises fiscal 2025 adjusted earnings per share from $2.35-$2.65 to $2.45-$2.65 versus the consensus of $2.55.
The generics player narrows 2025 sales guidance from $16.8 billion-$17.4 billion to $16.8 billion-$17.2 billion compared to the consensus of $17.24 billion.
The company said the outlook is based on the existing tariff and trade environment, and does not reflect any policy shifts, including pharmaceutical sector tariffs, that could impact business.
The company increased the Austedo 2025 sales outlook from ~$1.9-2.05 billion to $1.95-2.05 billion.
Teva reaffirmed sales forecasts of $600 million for Ajovy, about $160 million for Uzedy, and approximately $370 million for Copaxone.
Teva also raised operating income guidance from&nbsp;$4.1 billion-$4.6 billion to $4.3 billion-$4.6 billion, with adjusted EBITDA of $4.7 billion-$5.0 billion from $4.5 billion-$5.0 billion.
Price Action: TEVA stock is up 8.2% at $17.48 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45254006/bunge-q1-eps-beats-expectations-cites-tariff-driven-demand-shifts-as-tailwind" target="_blank" rel="noreferrer noopener">Bunge Q1 EPS Beats Expectations, CEO Credits &#8216;Tariff-Related Timing Shifts&#8217; As Tailwind</a></li>
</ul>
Photo: Shutterstock

Large Cap

Health Care

TEVA

Teva Shares Climb On Profit Beat, $700 Million Cost Plan, Biopharma Pivot Momentum

Press Releases

Viemed Healthcare Announces Date and Time for Conference Call

Viemed Healthcare Announces Record Second Quarter 2024 Financial Results

Viemed Healthcare Announces Third Quarter 2024 Earnings Conference Call Details

Viemed Healthcare Announces Third Quarter 2024 Financial Results

Viemed Healthcare Announces Year End 2024 Earnings Conference Call Details

Viemed Healthcare Announces Record 2024 Financial Results

Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

Comments

Viemed Healthcare

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO